Aspirin found to boost survival rate in cancer patients in new study

Categories: Others

Content Image

Aspirin found to boostsurvival rate in cancer patients in new study

A researchhas revealed that taking the over-the-counter painkiller aspirin has potentialbenefits that outweigh the side effects. Researchers at Cardiff Universityreviewed the earlier studies of aspirin and cancer and published the findingsin the journal Open Biology.

As per TimesUK, they found direct evidence that patients who took aspirin survived longerand also presented the biological mechanisms that might explain the effect.These include “reductions by aspirin in cancer-related inflammation,abnormal clotting and abnormal blood vessel growth, and enhancement in cellularrepair”.

Theresearchers said that several studies suggest that aspirin could boost survivalchances by about 20 per cent across different cancers. Some studies also pointout a reduction of about a third in the spread of cancer.

However,they stressed the importance of further evidence since different trials threwup varied results. They said that there “appears to be an impressive harmonybetween the biological effects of aspirin on mechanisms relevant to cancer, andthe effects of aspirin on clinical outcomes in cancer”.Going by theresults, they have deemed aspirin as a "relatively safe drug",especially among cancer patients.

Sam Godfrey,head of research information at Cancer Research UK, told Times UK, “Thisreview examines what we know so far about the fascinating effect that aspirinhas on the biology of cancer and how it might be helping to increase survivaland prevent cancer from spreading to other parts of the body. But we still needmore clinical research to establish how effective aspirin is, what patientswill benefit from taking the drug and how much they should take and for howlong."

“To helpanswer some of these questions, Cancer Research UK is funding Add-Aspirin, theworld’s largest clinical trial studying if aspirin can prevent certain types ofcancer from coming back.” Around 11,000 patients from the UK, Ireland and India are expected toparticipate in the new trial. These patients would have undergone treatment forearly-stage cancer to see whether regular aspirin use can prevent recurrence ordeath.

Top articles
Growing full crops in space First commercial space greenhouse to be launched in 2023 Published at:- The Calvine Photo A myth or world's clearest UFO photo that it released after 30 years Published at:- What do you need to know in the PEBC Syllabus Published at:- Aspirin found to boost survival rate in cancer patients in new study Published at:- Who invented chocolate or The earliest evidence of cacao was found in Ecuador Published at:- NASA Mars lander captures strikes by 4 incoming space rocks Published at:- Australian miner Fortescue reveals dollar 6point2 billion carbon plan Published at:- Approaching storm may delay launch try for NASA moon rocket Published at:- Why is a NASA spacecraft crashing into an asteroid Published at:- Tonga volcano blast was unusual could even warm the Earth Published at:- Earliest traces of opium use found in Israel may have been an offering to the gods Published at:- 3000 year old gold funeral mask unearthed in nobles tomb in China Published at:- Elon Musk extraordinarily welcomed this India conceived researcher to Twitter HQ Published at:- Crypto Very rich person Arthur Hayes Says Bitcoin May Crash Down If This Occurs This is The very thing that You Want to Be aware Published at:- China supported Blockchain Undertaking Proposes Quick Option for Stablecoins and CBDCs Published at:- Twitter to allow clients to pursue account suspension from this date Published at:- Joe Biden's budget proposals for 2024 and All you want to be aware Published at:-
Help4Study Team
The content on Help4Study.com website is created by expert teams.